Vircell, founded in 1991, is a biotechnology company specialized in the development and production of ready-to-use reagents for the diagnosis infectious diseases in humans. Its broad product portfolio includes over 500 references for detecting bacteria, viruses, parasites, and fungi using ELISA, CLIA, IFA, real-time PCR, and molecular quality controls. Vircell independently produces its own antigens, ensuring flexibility and high product quality. With global distribution in over 95 countries, the company operates under strict international standards and holds ISO 13485 and ISO 9001 certifications, with ongoing implementation of GMP standards.